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ABSTRACT (227 words)

Background & Aims
The severity of liver diseases is exacerbated by the death of hepatocytes, which can be induced by the sensing of Pathogen Associated Molecular Patterns (PAMPs)
derived from the gut microbiota. The molecular mechanisms regulating these cell death pathways are poorly documented. In this study, we investigated the role of the Receptor Interacting Protein Kinase 1 (RIPK1), a protein known to regulate cell fate decisions, in the death of hepatocytes using two in vivo models of PAMP-induced hepatitis.
Methods
Hepatitis was induced in mice by independent injections of two different bacterial
PAMPs: lipopolysaccharide (LPS) and unmethylated CpG oligodeoxynucleotide (CpG-DNA) motifs. The role of RIPK1 was evaluated by making use of mice specifically lacking RIPK1 in liver parenchymal cells (Ripk1
LPC-KO
). Administration of clodronate encapusated-liposome served to investigate the role of Kupffer cells in the establishment of the disease. Etanercept, a Tumor Necrosis Factor (TNF)-decoy receptor, was used to study the contribution of TNF-α during LPS-mediated liver injury.
Results
Whereas RIPK1 deficiency in liver parenchymal cells did not trigger basal hepatolysis, it greatly sensitized hepatocyte to apoptosis and to liver damages following single injection of LPS or CpG-DNA. Importantly, hepatocyte death was prevented by previous macrophage depletion or by TNF inhibition.
Conclusions
Our data highlight the pivotal function of RIPK1 in maintaining liver homeostasis in conditions of macrophage-induced TNF burst in response to PAMPs sensing.
Lay summary
An excessive hepatocyte death is a characteristic of liver injury. A new programmed cell death pathway has been described involving upstream death ligands such as TNF and downstream kinases such as RIPK1. Here, we show that in the presence of LPS in liver induced hepatic injury due to secreted of TNF by liver macrophages and that RIPK1 is a powerful protector of hepatocyte death. This newly identified pathway in liver may therefore be helpful in the management of patients in the prediction of their risk to develop acute liver failure.
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INTRODUCTION
The liver is constantly exposed to bacterial Pathogen Associated Molecular Patterns (PAMPs) such as unmethylated CpG-DNA motifs or lipopolysaccharides (LPS) originating from the microbiota of the gastrointestinal tract. In physiological condition, the intestinal barrier prevents the translocation of large amount of bacterial byproducts to the liver [1] . The low quantities of bacterial debris reaching the liver are efficiently cleared by phagocytic hepatic cells, which avoids induction of inflammation and harmful response [2] . In chronic liver diseases of steatosic or alcoholic origin, this intestine barrier function is damaged [3] [4] resulting in an abnormal elevation of PAMPs in the liver and impairing liver homeostasis [5] . PAMPs increase in the liver is one of the most common factor responsible for the outbreak of acute hepatitis on chronic liver failure background (ACLF for acute on chronic liver failure) [6] .
According to the European Association for the Study of Liver Disease (EASL) and the
Asian Pacific Association for the Study of the Liver (APASL), ACLF is an acute deterioration of pre-existing chronic liver diseases, and as a consequence, can provoke high short-term mortality. Thus, ACLF is, today, one of the most challenging fields in hepatology [7] . However, the molecular mechanisms responsible for the liver failure are incompletely understood.
Due to its anatomical link with the gut, the liver plays a key role in the bacterial clearance, which explains why ~80% of macrophages are in the liver [5] [8] . These liver resident macrophages, named Kupffer cells (KC) efficiently phagocytose bacteria and eliminate endotoxins in order to avoid systemic bacterial infection [5] . In addition to phagocytosis, KC are among the first cells to initiate the inflammatory response through the sensing of microbial products by the toll like receptors (TLRs) expressed at their surface or within their endosomes [8] . For example CpG-DNA and LPS respectively activate TLR9 and TLR4. Activation of TLRs contributes to ACLF by triggering an inflammatory response. Thus, LPS has been shown to contribute to cirrhosis, autoimmune hepatitis, primary biliary cirrhosis, alcoholic and fatty liver diseases both in humans and mouse models [9] [10] [11] [5] . Among proinflammatory cytokines released by LPS-activated-KC, TNF-α has emerged as a key factor in the inflammatory process, as levels of soluble TNF receptors correlate with endotoxin influx and liver injury [12] [13] . In mice, LPS intraperitoneal administration induces a systemic inflammatory response that can lead to death by septic shock, without inducing liver injury [14] . However, administration of LPS in a dietary NASH model or in combination with the hepatotoxic D-Galactosamine (D-GalN) in mice induces hepatocyte apoptosis in a TNF-α -dependent manner [15] [16] . D-GalN is metabolized into an active metabolite exclusively in hepatocytes and inhibits transcription by hepatic uridine nucleotide depletion [17] . Thus, it has been widely described that in the liver, NF-κB or transcription inhibition sensitizes hepatocytes to TNF-α -mediated apoptosis [18] [16] [19] . However, due to the pleiotropic role of TNF-α, anti-TNF-α therapeutic strategies in patients with alcoholic hepatitis are associated with an increased risk of infection and mortality [20] [21] . The Receptor Interacting Protein Kinase 1 (RIPK1) plays key roles in the signaling of several death receptors (DR) such as TNFR1 by deciding the cell fate between survival and death [22] . It has been recently reported that RIPK1 is implicated in epithelial cell death in intestine in TNFα and bacterial dependent manner [23] . As its role in the liver is poorly understood, we address here the potential role of RIPK1 in hepatocyte death induced by PAMPs and relayed by TNF-α, taking advantage of a knockout mouse line invalidated for the RIPK1 expressed in liver parenchymal cells (Ripk1
LPC-KO
).
MATERIAL AND METHODS
Animals and treatment protocols
Ripk1
LPC-KO mouse model has been previously developed [24] . LPS (Sigma-Aldrich, #L6761) diluted at 2 µg/mL in PBS was administrated by intraperitoneal (i.p.) route 
Genotyping
Genotyping was routinely performed using DNA extracted from tails with Nucleospin
Tissue kit (Macherey Nagel, #740952), and PCR with couple of primers for Alfp-Cre gene. Forward and reverse primers sequences were 5'-GCC TGC ATT ACC GGT CGA TGC AAC GA-3' and 5'-GTG GCA GAT GGC GCG GCA ACA CCA TT-3', respectively.
Preparation of liposomes-encapsulated Cl 2 MBP (Lip-Cl 2 MBP)
Liposomes-encapsulated Cl 2 MBP were prepared according to Rooijen [25] . In brief, 86 mg of phosphatidylcholine (Sigma-Aldrich) and 9 mg of cholesterol (SigmaAldrich) were dissolved in chloroform in a round bottom flask. After 4 h on a gentle rotation on a rotary evaporator at 37°C and under reduced pressure, the thin film formed was resuspended with 10 mL of PBS, and 1 g of Cl 2 MBP (Sigma-Aldrich).
After vigorous shaking for 1 min, liposomes in the saturated Cl 2 MBP solution were extruded through 1 µm diameter pores, followed by centrifugation at 10,000 g for 1 h. The Lip-Cl 2 MBP solution was diluted by half in PBS just before injection.
Histopathological and biochemical studies
Fragments of mouse livers were fixed in 4% paraformaldehyde and embedded in paraffin for IHC and hematoxylin and eosin (H&E). For histopathology, H&E staining of liver tissues was carried out to investigate liver injury. Serum ALT and AST transaminases were measured according to the IFCC primary reference procedures using Olympus AU2700 Autoanalyser ® (Olympus Optical, Tokyo, Japan).
Immunolocalization in liver tissues
For 
Protein extraction and western blotting
Mouse liver specimens were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4; 1 % Triton X-100; 25 mM HEPES; 150 mM NaCl; 0,2 % SDS; 5 mM MgCl 2 ), complemented with 1 mM Na 3 VO 4 ; 1 mM NaF and proteases inhibitors (Roche, #04 693 132 001), using 
Serum cytokine immunoassay by flow cytometry
Murine TNF-α, IL-6 and MIP-1α/CCL3 cytokines were quantified by bead-based immunoassays according to manufacturer protocol, using a filter plate and a vacuum filtration system for washing steps (BioLegend's LEGENDPLEX, multi-analyte flow assay kit). Samples were analyzed on a LSR Fortessa cytometer (BD Biosciences).
Statistical analysis
Data were expressed as means +/-SEM for all mice treated similarly. Kruskal-Wallis one-way analysis of variance (ANOVA) was performed, and mean differences between experimental groups were assessed using the non-parametric Mann- 
RESULTS
Deficiency of RIPK1 in liver parenchymal cells sensitizes to liver damage induced by PAMPs
To investigate the role of RIPK1 in the liver, we used the Ripk1 LPC-KO strain mice which presented a specific deletion of RIPK1 in liver parenchymal cells (Supplementary Figure 1) . As described previously [24] , these mice, as well as their (Fig. 1B ). These were even more significant in Ripk1 LPC-KO mice subjected to LPS administration ( Fig 1C) .
In order to evaluate whether RIPK1 deficiency had any impact on the systemic inflammatory response, we measured the levels of serum pro-inflammatory cytokines in CpG-DNA or LPS injected mice. Administration of CpG-DNA triggered a quick release (1.5 h pi) of TNF-α and IL-6. Whereas TNF-α returned at its basal level 8.5 h post-injection, serum IL-6 quantities remained high. However, no difference was observed between Ripk1 fl/fl and Ripk1 LPC-KO mice ( Fig. 2A) . We next evaluated the same cytokines but also the chemokines MCP1/CCL2 and MIP-1α/CCL3 in sera from LPS injected mice. Interestingly, absence of RIPK1 did not affect the early (1.5 h p.i.)
release of IL-6, CCL2 and CCL3 but weakly increased serum TNF-α levels, and led to a significant sustained expression of TNF-α, CCL2 and MIP-1α/CCL3 at the time of apoptosis induction (8.5 h p.i.) (Fig. 2B ). In the same manner, PAMPs injection triggered TNF-α, CCL2 and CCL3 liver transcription. However, Ripk1 LPC-KO mice more expressed these cytokines 8.5 h after PAMPs administration which correlated with liver damage (Supplementary figure 2) . Moreover, H&E coloration and myeloperoxidase (MPO) labelling of liver sections showed higher infiltrations of inflammatory cells in Ripk1 LPC-KO mice after LPS administration (Fig 1B-1C and Fig   2C) . Thus, whereas CpG-DNA triggered a moderate hepatolysis associated with low inflammation, LPS administration induced severe acute hepatocyte death which were associated with more extended pro-inflammatory cytokine expression and more important recruitment of inflammatory cells when RIPK1 were absent in liver parenchymal cells. Thus, to better understand the protective role of RIPK1 during hepatitis induced by PAMPs administration, we continued experiments with the LPS model. figure 3A) . This proved the effectiveness of our pretreatment. Accordingly, the early LPS-mediated increased in serum levels of CCL3 and IL-6, two cytokines mainly produced by macrophages, were significantly reduced in mice pretreated with Lip-Cl 2 MBP (Supplementary figure 3B) . Interestingly, macrophage depletion greatly rescued the liver damage induced by LPS in Ripk1 LPC-KO mice. Indeed, Lip-Cl 2 MBP pre-treatment massively reduced LPS-induced serum transaminase levels (Fig. 3A) , which was associated with a reduction of necrosis areas, of TUNEL positive cells as well as of apoptotic cells ( Fig. 3B and 3C ). (Fig. 5C ).
Depletion of Kupffer cells reduces LPS-mediated hepatitis in
TNF-α produced by Kupffer cells mediates LPS-induced liver damage in
Ripk1
DISCUSSION
Hepatocyte death is a key trigger of liver disease progression [32] . During chronic hepatitis, acute hepatocyte death can occur and causes ACLF, and induces quick and high mortality rate in patients [7] . One of its main cause is the elevation of gutderived-microbacterial products in the liver [6] . PAMPs activate TLR receptors, expressed at the surface of innate immune cells, such as KC, inducing cytokine release which promotes liver inflammation and hepatocyte death, eventually leading to liver failure [8] . Elevation of bacterial products in the liver can be mimic by LPS or CpG-DNA injection in mice. In healthy liver, their administration induces a quick delivery of cytokines without triggering liver injury. However, during ACLF, Previously, we showed that RIPK1 plays a key protective role in murine hepatocytes when TNF signaling is triggered by concanavalin A, a model of T-cells induced hepatitis [24] (see extended discussion). These supported our herein data showing that physiological production of TNF-α by LPS-activated KC led to hepatocyte apoptosis in Ripk1 LPC-KO mice. The role of soluble and transmembrane TNF-α in LPSmediated hepatitis is currently discussed [41, 42] . As Etanercept blocks both forms [43] , we cannot distinguish the more active one in our experiments. However, although no conclusions can be drawn from our experimental model on tm-TNF involvement, we can conclude that its soluble form was sufficient to promote liver injury. Indeed, LPS triggered high release of soluble TNF-α in the bloodstream and single soluble recombinant TNF-α injection is able alone to trigger acute hepatocyte apoptosis in RipK1 LPC-KO mice [24] . TNF-α can generate intracellular signaling through interaction either with TNFR1 or with TNFR2. However, TNFR1 seems to play a predominant role in the liver [44] . Thus, in the TNF-α/D-GalN hepatitis model, the deficiency of TNFR1 in liver parenchymal cells is sufficient to fully protect animals against liver damages [45] . Taking into account the different aspects discussed above, we proposed a schematic model on the vital role played by RIPK1 to maintain liver homeostasis under elevated PAMPs conditions (Fig. 6 ).
In conclusion, the sensitivity of Western-blot analysis of RIPK1 and β-actin, in protein extracts issued (A) from the liver, (B) or from primary hepatocyte cultures (PH) of WT or Ripk1 LPC-KO mice.
Total RNA was extracted, from mouse liver tissues by using the NucleoSpin RNA II kit (Macherey Nagel #740955). First-strand cDNA was synthesized using the 
Extended discussion
The concanavalin A (ConA) model mimics some features of auto-immune or viral hepatitis in mice. Indeed, this lectin activates T-lymphocytes and more specifically NKT subset in an antigen-independent manner [2, 3] . Thus, hepatocyte death is induced in a DR-dependent manner, also requiring the production of TNF-α, IFN-γ and IL-4. Closer to physiopathologic conditions, PAMPs administration allows to study the role of innate immune cells activation, such as Kupffer cells, in the development of hepatitis. Inflammation induced in this condition is important to control bacterial burden but in return it can provoke collateral tissue damage which is a cause of ACLF [4] . In WT animals, ConA induced a complex inflammatory environment which leads to hepatocyte lysis whereas single administration of PAMPs alone is ineffective. Altogether, these characteristics underline the complementarity of both models. The exacerbated liver injury associated with a sustained inflammation (certainly promotes by the release of DAMPs issued from dead hepatocytes) observed in Ripk1 LPC-KO mice during ConA [5] or PAMPs challenging highlights the importance of RIPK1 as a protector of hepatocytes during immune-cells stimulated conditions and TNF-signaling. These new data enlarge our knowledges on the RIPK1 platform functions in hepatocytes which were until now questioned as recently underlined by Dara and colleagues [6] .
